throbber
,,; we-'
`
`.3"
`
`V *’’’'W
`’ Wm
`
`"&'5
`j
`3
`wéna
`i
`3
`r:
`V
`
`“mass: ..
`
`, ‘
`
`5
`
`A
`
`*° <
`
`_. X
`v
`’
`. ” ‘
`
`.
`
`'
`
`—
`

`
`GENERAL §§EM€28f:\§E
`
`35$?! EDITEGN
`
`I PS EX. 2166
`
`CFAD V. NPS
`
`I PR2015-00990
`
`Page 1
`
`NPS Ex. 2166
`CFAD v. NPS
`IPR2015-00990
`
`

`
`THE
`
`MERCK
`
`MANUAL
`
`FIFTEENTH EDITION
`
`1st Edition —‘ 1899
`2nd Edition -1901
`3rd Edition — 1905
`4th Edition — 1911
`5th Edition — 1923
`6th Edition— 1934
`7th Edition —- 1940
`8th Edition — 1950
`
`9th Edition— 1956
`10th Edition -1961
`11th Edition— 1966
`12th Edition- 1972
`13th Edition~— 1977
`14th Edition- 1982
`15th Edition- 1987
`
`VOLUMEI
`
`GENERAL MED1C|NE
`
`Page 2
`
`
`Page 2
`
`

`
`FIFTEENTH EDITION
`
`THE
`
`IVIERCK
`
`MANUAL
`
`OF
`
`DIAGNOSIS AND THERAPY
`
`VOLUMEI
`
`GENERAL MEDICINE
`
`Robert Berkow, M.D.. Ea‘/tor-/n-Ch/ef
`
`Andrew J. FIetcher, M.B., B.Chir., Ass/sz‘éntEa’/tor
`
`Ed/tor/a/I Board
`
`PhiIip K. Bondy, M.D.
`L. Jack Faling, M.D.
`Alvan R. Feinstein, MD.
`Eugene P. Frenkel, MD.
`Robert A. Hoekeiman, MD.
`Robert G. Petersdorf, MD.
`
`Fred Plum, MD.
`John Romano, MD.
`G. Victor Rossi, Ph.D.
`John H. TaIbott, MD.
`Pauf H. Tanser, MD.
`
`Published by
`
`MERCK SHARP & DOHME RESEARCH LABORATORIES
`D/‘v/‘s/on of
`MERCK & Co., INC.
`Rahway, N.J.

`1987
`
`Page 3
`
`
`Page 3
`
`

`
`MERCK & CO, INC.
`
`Hahway, N.J.
`U.S.A.
`
`MERCK SHARP & DOHME
`West Point, Pa.
`
`MERCK SHARP 84 DOHME INTERNATIONAL
`Hahway, N.J.
`
`MERCK SHARP & DOHME RESEARCH LABORATORIES
`Rahwa y, N../. West Point, Pa.
`MSD AGVET DIVISION
`Woodbridge, N.J.
`
`HUBBARD FARMS, INC.
`Walpole, N. H.
`
`MERCK CHEMICAL MANUFACTURING DIVISION
`Hahway, N.J.
`
`CALGON CORPORATION
`Water Management Division
`Pittsburgh, Pa.
`Commercial Division
`St. Louis, Mo.
`
`KELCO DIVISION
`San Diego, Calif.
`_._.._____.___.___._.__._
`
`Library Of Congress Catalog Card Number 1—3176O
`ISBN Number 0-91 1910-07-7
`ISSN Number 0076-6526
`
`First Printing——August I987
`
`COpyrigl'Iz© $987 by MERCK 8: Co., NC.
`AH rights reserved. Copyright under the Universat Copyright
`Convention and the internationai Copyright Convention.
`Copyright reserved under the Pan»American Copyright Convention,
`Prmwd ir xhe U, S A.
`
`Page 4
`
`
`Page 4
`
`

`
`M
`48 infectious and Parasitic Diseases
`tenderriesss over the ilexor tr;-moo":
`signs
`generalizeri swelling and inflammation of" me finger,
`
`sheaths. Careful maintenance of a flexed finger A
`mom. and exouiszire pain on active or D€3SSlV(;'
`
`izriger extension Fever, lyrtipharigitis, lymphaden is, and leumcytosis are usual. Treatment is surgi-
`cal oramage plus antibiotics. Gram stain of the pus should o‘=c:ate axiiil:iotic choice: streptococci and
`staphylococci are the usual pathogens.
`
`K,
`
`6. BACTEREMIA AND SEPTIC SHOCK
`
`i‘ to term septicemia is reserved for
`Bacteremia connotes invasion of me C.n'Cu.-"ar‘.fon by bacteria.
`srtuar/orig /n which bacteremla /5 £’5SOClar‘Ed win‘; clinical ma.rr:1’esra:rans 0/ //vfecricrr. Bacteremla
`COWWOWY. 8575 U3l«‘3llV Vanslently. accompanies various surgical rrianipuiations (eg, incision of an
`abscess); or it may result from colonization of indwelling intravenous devices and urethral catheter“.
`
`(For infants, see also NEONATAL SEPSlS AND NEONATAL MENlNGlTlS under NEONAYAL INFECTIONS iii v1 .
`ll. Ch. 23.) Bacteremia may be intermittent or sustained, and may cause severe conseouences. in
`patients who abuse IV narcotics. grarmpositive bacteremia is comrnori and may lead to rightsided
`bacterial endocarditis even in the absence of cardiac murrnurs. The oaclerernia of left-sided bacterial
`endocarditis is usually sustained and may be prolonged. Grarrwegative bacteremia lS usually inter-
`mittent and generally fol-ows primary infection in the GU tract, biliary tree, Gl tract. lungs, or
`less
`
`C0-‘=”>mG"lV. skin. bones. or joints.
`in many patients with chronic diseases no primary focus oi i
`tion is apparent.
`Symptoms and Signs
`Few clinical manifestations are unique to bacteremia. Although variable, fever lS almost always
`present and may be intermittent, with wide diurnal variations (septic. or "sp%l<ir~g“}, Chills are coin
`man at the onset Skin eruptions are also common, and may be petechial. purpuric. papular, pusluiat,
`or vesicular. Usually gram—negative bacteremia begins abruptly with chills, =‘over, nausea, vomiisrig,
`diarrhea, and prostration,
`Diagnosis
`The presence of bacteremia is established by blood cultures, which should be perlorrneo for both
`aerobic and anaerobic organisms. A single negative culture does not exclude bactererma; moreover,
`in some patients, especially those with préor antibiotic therapy, blood cultures never do become
`positive. li the patient is not very ill, no more than 6 blood cultures should be performed, In severely
`ill patients. 2 blood cultures taken 30 min apart before treatment is irstitured slioulo suffice. in most
`cases, treatment is required before results of blood Cultures become available.
`Complications
`Metastatic infection of the meninges or of serous cavities, sucln as the pericardium or larger
`joints. may occur. Endocarditis (see also ENoocARDms in Ch. 27) may be the sequel 0‘ bacterernia ii
`the pathogen is a streptococcus or staphylococcus, but rarely occurs
`a result of gramwiegative
`baoteremias. Metastatic abscesses may occur almost anywliere and, when extensive, produce
`symptoms and s=gr2s criaracterrstie of infection in the organ affected, Multiple abscess formation is
`particuarly common with staphylococcal baclererriia. Bacleremia may result iI'1 septic shock, wiiir;
`$3 discussed separately. below.
`Prognosis
`iary
`iiidwellrg l\/ catheters; or
`Transient baoteremias associated with surgical procedures,
`ca‘rhete"s are often undetected and probably do not require therapy. However, persgstent bacteremia
`is dangerous; the prognosis depends on the ability to el rriinaie the source of infection with s gery
`or antibiotics, and on the status of the underlying disease. When multiple organisms are recovered
`consistently (polymicrobial bacteremia). a poor outcome can he expected. Bactarernse unresponsive
`to treatrnerit because 0‘ inadequate entibiobc therapy. poor host resistance, or delay in i§lagTiOSl$ is
`often fetal.
`Treatment of baoteremia is discussed below with septic shock,
`
`
`
`SEPTIC SHOCK
`Wnen bacterernia is associated with inadequate tissue perfusion, especialiy with gram—rregative
`re
`organisms or meningococci. septic shock with hypotension. vascular collapse, renal failure. and
`death may ensue. Septic shock usually occi when bacteremia is due to grarn—rtegative organisms
`and generally in hospitalized patients with underlying diseases. Pre-disposing factors include diabetes
`meilitus; cirrhosis: leukemia; lymphoma; disseminated carcinoma: surgical procedures: antecedent
`
`_
`
`, ,_ ..--A.._._._....—-1
`
`Page 5
`
`
`Page 5
`
`

`
`Bacteremia and Septic Shock 49
`-
`ch, 5
`iniection in the sririary, bzliary, or Gl tracts; indwelling l‘v’ catheters. treatment with antibiotics, step
`aids, gyrotoxic: agents, or inhalation ecurprnent. Septic shock occurs more often In the elderly and in
`zrze newbor :.
`b
`I
`The pathogenesis of septic shock depends upon vasoconstrictson oi the smail arteries and veins.
`w'hi(,n leads to increased peripheral vascular resistance, pooling cl blood an the microcirculation, and
`decreased cardiac Output. With poor perfusion there is tissue anoxia anc the decreased blood vol.
`time results in nypotension and oliguria. These vasoactive phenomena are related largely to release
`of endotoxin, the lipopolysaccharide moiety of gram-negative ‘ceciliary Cali. walls, into the circulation,
`Symptoms and Signs
`Manifestations of bacteiamia (see above) usualiy appear first. V\/nevi septic shock develops, there
`are,
`in addition, tachycardia: tachypnea; nypotension: moi. Dale extremities (often with peripheral
`cyariosis); mental obturidation; anc oligtiria. Occasionally the findings are subtle, especially in elderly,
`debilitated patients or infants. Unexplained ‘nypotension,
`increasing confusion and disorientation.
`‘nyperpnea, or oliguria due to decreased renal blood flow may
`the only early clues to gram~r‘=ega-
`
`trve‘shocl<. As shock progresse
`nadecuate renal perfusion may lead to acute renal failure. Cori’
`gestive heart failure, respiratory insufficiency, and coma may progress to dean .
`I
`Different hemodynamic patterns are characteristic of endoroxin-related shock. Some patients have
`normal blood volume, venous pressure. c:irr:uiation time, and cardiac output, but have decreased
`peripheral resistance. These patients have warm, dry skin; often they also have cirrhosis. The progno-
`sis in this type of "warm shock!’ is good unless local acidosis, a consequence of irieifective tissue
`perfusion and impaired oxygen utilization, eventuates in decreased biood volume. central venous
`pressure, and cardiac Output. with by-poterision and oliguria. This 5-iernodynamic pattern may be
`present initially Or may follow a period of warm shock.
`Most patients with septic shock have deficiencies in several clotting factors, probably due to their
`Consumption in the process of disseminated imravascuiar coagulation {see Ch. 99). Respiratory fail-
`ure characterized by decreased pulmonary compliance and irreversiole hypoxia. called "shock lung”
`(see Ch. 35), may ensue even after hemodynamic abnormalities have been corrected.
`Laboratory Findings
`laboratory data in bacteremia and septic shock vary greatly and depend in rrrany instances on the
`cause and stage of hemodynamic decompensation. Usually, leukocytosis of between l5,000 and
`30,000 WBC/i1L with a left shift is present However. relative or absolute leukopenia may be pres-
`ent in severe cases, particularly early in the course. The platelet count is usually decreased. Urinalysis
`reveals no specific abnormality.
`initially the urine sp gr is increased. However,
`if oiiguria persists,
`isosthenuria may develop. The BUN and creatinine are increased, and creatinino clearance declines
`Electrolytes vazy considerably, with a trend toward hyponatrernie and ‘rzypocnloremia. Potassium may
`be low or high depending upon the ability of the kidney to excrete this ion.
`Respiratory alkalosis, with a low P502 and increased arteria1pH. is present early and comps ‘rrres
`for lactic acidemia. Serum bicarbonate is usually low, while blood lactate is increased. A.-5 s
`‘
`
`progresses, metabolic acidosis supervenes. Hypoxemia with P02 < 70 mm Hg is common. ‘rie;Trocy—
`namic measurements vary as described above. The ECG shows depressed ST segments with T‘ wave
`inversions and various arrhythrnias.
`Treatment
`Overall mortal ty in septic snock ranges from 50 to 90%, if mild
`
`ctrr; acidosis is severe.
`present, the prognosis is good, t-
`;
`3“
`
`
`
`snt‘2:ig" C=n..~‘
`d, shock
`often
`peirsated metabolic a dosis pace
`cause most patients liiaE“_/ to eveéop
`y:=ripto;ns an
`, sivorik are in *" hospital b
`
`of slrocir appear, this grave
`i‘
`or infection is of ..
`» avo¥‘«a‘r.>le by vigilant care
`’
`Patients with septic: snr
`sled}
`.
`iv
`c is _t="li!S Pulrnoriary artery and systemic
`pressures, arterial and y'€=i>E>.
`5 pH. artenal blood gases:
`plate, renal furiclioi‘, am elect"cw‘y'es
`
`should be ¥nO!"lf0i'E‘.'g ‘i
`,
`n _[){O\:’idS.‘; a clue to iiuiph
`1
`resistance. but does not accurate
`gy. brain, or gm Trierszrore,-*1‘
`output sht:-iisd be used to mom
`ffriaflclirlic blood flow a d visceral r
`.osi0z‘.
`lndweli
`oath»,
`s
`usually recurred.
`Fluid therapy: The central venous pressure {CVP) or pulmonary artery pressure shouic‘ be mea~
`sired in every patient, and fluid replacement given until the CV? reaches ll} to ‘:2 cm of water o’
`until the pulmonary wedge pressure reaches 12 to 15 mm Hg. Blood volume should be replaced
`with blood if anemia is present; otherwise. plasma, dextran, human serum abumin. or appropriate
`eiectlfilyte solutions {usually dextrosesaiine with bicarbonate. which is preferable to lactate) are
`used. Ollguria in the presence of bypotension is not a contraindication to continuing vegorous fluid
`l*l9l'5r'3Y- The Quantity of ilurd required often
`exceeds the riormal blood volume and may amount
`{O 8 $0 1:2 L in a few hgurg,
`
`
`
`_
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 6
`
`
`Page 6
`
`

`
`
`
`
`
`50 infectious and Parasitic Diseases
`
`5’:
`
`tracheal intubation, or tracheostomy as
`Respiration should be supported with nasal oxygen.
`necessary. The pulrronary artery pressure may be the best guide for anticipating incipient pulmonary
`edema. Treatment of shock lung is described in Ctr. 35.
`Parenteral, bactericidal antibiotics sliouzd be administered after cultures of biood and approprr
`ate sites have been taken. Usually at the onset of bacteremia or septic shock, while awaiting cultures
`and sensitivities, an etiologic diagnosis entails an educated guess based on previous cultures from a
`primary focus or on the setting in which
`action occurs. Pus must be drained and foreign bodies
`and necrotic tissue must be removed Failure to do so often results in a poor outcome despite
`antbrotir; therapy. Specific therapy »s the serve as for me primary infection, but more intense. Since
`early acirninistratron of antibiotics may be critical to save the patient‘s life, an effective regzmen for
`
`
`bacreremia of unknown etiology before arm :rCfObl8i sensltr ties are known is gentamicin or tobra~
`mycin 3 to 5 mg/kg/day llvi or lV plus either rtafcillin 4 to 8 gm/day iv or a parenteral cephalosporin.
`Carbenicillin or trcarctllin 30 grrr/day lV may be added if Pseudomcnas .5 susoected. As soon as
`cultures have revealed the putative pathogen. unnecessary agents are stopped. Antibiotics should be
`continued for several days after shock has resolved and the primary focus of infection has healed
`adequately.
`Vasoactive drugs, pa:'7%cu:‘ar.y alph5~.receptcr blocking agents leg, phenoxyberxzamine) or beta—re~
`ceptor stimulators leg. rsoproterenol) have been of value in septic shock. Dopamine is now the
`preferred agent because it erihartces renal pertusion. The response to therapy is determined clinical.
`ly. and return of peréusron to norrrial :s the best guide to stopping vasopressors.
`
`
`
`itrgate ‘me cellular
`Adrenal corticosteroids ii‘
`lar
`doses suppn" peririh ral resists ce and .
`
`
`
`
`
`
`
`
`'
`’
`...etr us: .
`$~.3«re:s.tt£, nwst cirrrruram v‘~zl3I
`~’i§4..';"/ Se
`’
`C} Eng
`'lV7:‘$ 39
`
`mg,/kg meihylprednrsolorro as a bolus and rep at it at 6- to l2—h intervals for 24 to 48 ii.
`Control of hemorrhage, with fresh frozen p?asrna when it
`‘IS a cor-sequence of clotting factor
`rieficiency or wtth platelets when due to znrombocytoperna, is importart.
`
`Surgical intervention to drain absce
`s or excise irttecr-ed tissuesweg, lniarcteo bowel. inflamed
`galstiiacmer,
`infected uterus. or pyc
`{.>hrOSiS——~ShUi,'id be performed. The patient's condition. al«
`though grave, rnav rzontanue to date ’
`rate unless the septic food is re oved or drained.
`Other therapeutic modalities are indicated, ceoending on the patients clinical status, and include
`
`marmtel or furoeernirie to induce diuresés :n patients with oligurie, a rapidly acting digit
`3 preoara—
`tion in patients with hea
`failure.
`or:<:as.onal'y. heparin in patients with disseminated zntravascu—
`lar coagulation.
`
`
`
`7.
`
`INFECTIONS lN THE COMPROMlSED HOST
`
`/nfacrrons ranging from ff”/z'»"lO.’ to fatal. caused by norma//y nonpat/vogemc organrsms in patients
`whose frost‘ defense mechanisms nave been compromrsed. Malnly,
`the problems presented take
`place in the rospital setting and are the prtce at medical advances that have erzablad us to deal more
`ettectiveiy with prEv'OLl$iy unmanageable disorders. Noscrcornial
`infection in the newborn is dis-
`cussed under NEONATAL mrecrrons in vol, ft, Ch. 23.
`Etiology
`9-lost defense mechanssmsmphysiologic. anatomic. or immur‘roiogi:——may be altered or breached
`by disease or trauma, or by procedures or agents used for atagnosis or there y. infections occurring
`in this setting, also uafled opportunistic infections, are seen if antirnicrobial therapy alters the nor-
`mal relationship between host and microbe, or if host defense mechanisms have been altered by
`burns. anemia, other inferztéons. neoplasms, metabolic disorders. lrraoiiatéon, foreign bod:es.immu1o~
`suppressive
`cytotoxic drugs. corticosterosds, or diagnostic or therapeutic instrumentation.
`The underfyirig alteration oreoisposes the patient to irziections lrarri his usually rzollfiaf-‘IUQBMC
`endogenous microfiora or irorn ordinarly lnarrnless. saprophytlc Organisms acquired by’ Collie“ Wl‘3li
`other patients. hospital personnel. or equiprnerit. Managernent is complicated by the ‘ad Illa‘ 159
`
`orgarisrrrs that oopor’ttmisti<:ally take advantage of the r:ornprontis‘%d host ii uallv are resstant to
`antibiotics. lhese organisms may be bacteria. fungi. viruses. or other n .as‘
`and ‘me '»
`
`
`
`
`
`aracter of the host 3 alte-re-5: defenses detarrnirres which Wganisrns are T081 ll
`:lv Y0 U VM/Olvéd.
`1. Antibiotic resistance and impaired anatomic host defense mechanisms: Antimicrobial treat
`
`
`ment alters the nor: al miciotlora of N“
`skin. mucous membranes. and G’ tract and may result .r*
`
`
`i
`:
`r of these organs. Coloniz ‘Jon oer se is narrniess uniests §Ol‘3V*"~’:d 53’ 3Ul3el’l"f9‘3t5°“
`
`
`-Cir-:;a.<;}on by erxdcrgenous or ertvsrorzrrten as organisms ~’eS'Siar\i to the ant
`lotto hemg given), which is
`
`demonstrable mécroruolog ally or cirn.
`llv. Factors predisposing to superinlecliori iriglude smremes
`of age, chrome irifectig-=1 or other d€l}lliIaIlllg di;-:
`e><cess.ive doses 0: one or serve-:al arrtimicroimu
`
`Page 7
`
`
`Page 7
`
`

`
`502 Puimonary Disorders
`can best be relieved by surgery, radiation, or chemotherapy.
`efi‘ective¥y reduced obstruction from an endobronchial lesion.
`
`M
`in selected cases, laser therapy has
`
`I
`
`39. PULMONARY EMBOUSM (PE)
`(Thromboembolisrn)
`
`éodgnieni ofa brood clot in a pulmonary artery wir.'r,« subsequent obstruction of b/ood supp/-,' to the
`lung parenchymar Pulmonary infarction (Pl); Hemorrhagic consolidation {often fa//owed by necro-
`sis) of /ung pa/anchyma resu/I/ng from mromboembo/rc pu/monary arterial’ occlusion.
`Etiology and Pathogenesis
`The most common type of pulmonary embolus is a thrombus that usually has formed in a leg or
`
`pelvic vein. Most of those causing serious hemodynamic disturbances form in an ilioiernorai vein,
`either de novo or by propagation from cali vein thrombi. Thromboemboli that originate in the ve
`of
`the upper extremities or in the right cardiac chambers are infrequent. Amniotic fluid emboli and rat
`emboli following fractures are rarer types of’ PE whose primary site of vascuiar obstruction is the
`pulmonary rnicrocircuiation (arterioles and capillaries rather than pulmonary arteries); izivoivemerit of
`
`the microcirculation may initiate the so-caiied adult re
`ratory distress syndrome (see in Ch. 35}
`
`‘Pi is an infiequerit {< 16% oi cases} conseouerace or Fe. it is sour» imes due it; ihr
`of the pulmonary arteries as might occur in congenital heart disease associated with severe puimnv
`nary hypertension or in hematologic disorders (eg. sickle celi anemia).
`The pathogenesis of venous thrombosis involves stasis. increased blood coagulability, and vascuiar
`wall damage (Virchows triad). Factors predisposing to tnromboembolic disease inciude prolonged
`bed rest with irnmobiiity, chronic heart failure, the postooerativerstate, pregnancy, hip fracture. use
`of oral contraceptives, cnronsc obstru<;tive pulmonary disease (COED), obesity. malignancy’, friernato~
`logic disorders (eg, polycythemia Vera), vascular inguries resulting from minor trauma, and immobiliza-
`tion with stasis as may occur in chronic disease states, in ,. any patients, no predisposing factor can
`be found.
`Once released into the venous crculation, embcli are distributed to both lungs in about 65% of
`cases. to the righ: lurig in 20%, and to the left lung in 10%. Lower lobes are ‘mvoived 4 times more
`often than upper lobes. Most thromboemboli lodge in larger or intermediate (elastic or muscular)
`pulmonary arteries: 35% or fewer reach the smaller arteries.
`Pathophyslology
`The pathophysiologéc changes that follow PE invciive adjustments in oulmonary hemodynamios,
`gas exchange, and mechanics. The extent of change in cardiopulmonary function is determined by
`the extent of pulmonary arterial obstruction, which varies with the size and number of thrombi
`embolizing and obstructing the pulmonary arteries. and by the patients preennbolic cardiopulmonary
`status. A consideration of the pathophysiology of PE must include the mechariisrris responsible for
`the following: (l) pulmonary hypertension, right ventricular failure, and shock; (2) dyspiiea with ta-
`chypnea and hyperventilation; (3) arterial hypoxemia; and (4) Pl.
`1. Pulmonary hypertension, a most important physiologic aiteration, resuits from increased pul-
`monary vascular resistance. As a consequence, the right ventricle must generate higher pulmonary
`artery pressure to maintain normal CO. Significant pulmonary hypertension (> 25 mm Hg mean
`pressure) usually occurs only when > 30 to 50% of the pulmonary arterial tree is occluded in a
`previously healthy lung. Pulmonary hypertension may be increased by preexisting cardiopulmonary
`disease (eg, mitral stenosis or obstructive lung disease).
`
`The primary mechanism of increased resistance is obstruction of pulmonary arteries by thrombi
`a decrease in the total cross-sectional area of the pulmonary vascular bed. l-lowevery because some
`degree or’ pulmonary hypertension often develops with obstruction of < 50% of the vascular bed,
`pulmonary vasoconstriction appears to play a definite, but secondary. rote. Vasoconstriction is partly
`mediated by hypoxemia, by serotonin release from platelet aggregates on me thrombi, and possibly
`by other humeral substances, zncfudmg prostagiandins.
`if pulmonary vascuiar resistance nncreasas acutely to the extent that the right ventricle cannot
`generate sufficient pressure (ie. > 70 to 80 mm Hg systolic‘ to maintain CO, hypotension develops
`(in which the central venous and right atrial mean pressures are increased). This occurs only after
`massive embotizatmn involving at least 50% and usually Z’5‘i/c or more of the pulmonary vascular bed
`without preexisting cardiopulmonary disease With severe hypoteneion and shock, mean central
`venous pressure tends to fall
`2. Techypnea, often with dyspnea, aimost always occurs after an emboic episode. it appears to
`be of reflex origin, most iikely due to stimulation of iuxtacaoillary receptors in the alveolar capillary
`
`I
`
`.
`
`,
`
`.
`
`Page 8
`
`
`Page 8
`
`

`
`Ch. 39
`Pulmonary Embolism 503
`mernbrane by swelling of the alveolar rnte'ststial space. Tris stirnulation increases vagal afferent
`gct'v:‘.y that in turn stimulates rnaduliarv f€SDll’8lO5"y neurons. Consequent alveolar hyperver-tilation is
`manifested by a lowered Pacijg.
`Following occlusion of the pulmonary artery, areas of the lung are ventilated but not perfused.
`;esi,-lting in "wasted ventilation" {the plrysiolo-git: hallmark ol P‘E). The existence of wasted ventilation
`
`the settrg of acute PE is signaled by increased arterial-alveolar CO2 tension differenr
`reflecting
`
`augmented -
`“
`siologrc oeadspace, but this is not specific tor 9E;
`t occurs also V‘.‘i‘.'= coexisting
`pulmonary disease. as well as systemic hypotension.
`Changes tend to occur in lung mechanics as airways resistance increases and lung compsiance
`decreases. A decrease in the rnaxrrnal expiratory flow rate results from cirninished lung volume and
`possibly from ‘oronchoconstriction. Reduced lung volume following PE sornezirnes is manifested on
`the chest x«ray by elevation of the diaphragm due to atelectatrc or intarcted segments. Heparin
`appears to lessen oronchoconstriction, when present, as evidenced by improved maximal expiratory
`ilow rates. Since changes in ‘Ling mechanics are usually transient and manor, they are unlikely to be
`important in the genesis of prolonged dyspnea. However, they probably‘ contribute to development
`of arterial hypoxemia, described below,
`3. Arterial hypoxemia: S302 is characteristically diminished (94 to 85% or lower)-. but may be
`normal. Hypoxernia is due to right-to-left shunting in areas of partial or complete atelectasis in areas
`not involved by the embolic process. Characteristically this atelectasis can be partially corrected by
`deep breathing. either voluntary or induced by a positive pressure ventilator. Ventilatiori/perfusion
`(‘~71/‘{5} rnbalance probably also contributes to the liypoxsmia. The mechanisms responsible for the
`W./C‘) imbalance and atelectasis are not fully defined. One important factor relates to regional chang-
`es in compliance. which together with hyperventilation sets the stage for varying degrees of airways
`hypocapnia. producing nonuniform constriction of distal airways and peripheral lung units. Under-
`ventilation of the units results with respect to perfusion. and atelectasis ensues it these changes are
`severe. Tachypnea may augment the changes. in "nassive embolization, severe hypoxemia may result
`from right atrial hypertension that causes right-to-left shunting of blood through a patent forarnen
`ovale.
`4. Pulmonary infarction (Pl): Most PE do not produce infarction. When bronchial circulation is
`‘intact and normal (is.
`in the absence of neart failure or underlying mronic lung disease). Pl rarely
`develops. This suggests that collateral circulation of the bronchial artery keeps the lung tissue viable
`despite blockage of the puirnonary artery. However, patients with previously abnormal pulmonary
`circulation are prone to develop Pl. Such infarcts may heal by absorption and fibrosis, leaving a linear
`scar, or may resorb completely. leaving a normal lung (incomplete infarction).
`Acute PE is a dynamic process. Thrombi begin to iyse immediately after reaching the lung. Usually,
`complete clot lysis takes place within several weeks in the absence of preexisting cardiopulrnonary
`disease. but, in some instances, even large thrombi may lyse in a few days. The physiologic altera-
`tions lessen over hours or days as the pulmonary circulation improves. Massive emboli may cause
`death within minutes or hours without sufficient time for infarction to develop. Smaller ernboli may
`produce infarction that can heal with recarialization and restored blood flow. lnfrequently, embolic
`events recur for months or years, causing progressive pulmorary arterial obstruction with chronic
`pulmonary hypertension. increasing dyspnea, and cor pulmonale.
`Symptoms and Signs
`The clinical manifestations of PE are nonspecific. Diagnosis may be diflicult without using special
`procedures. the most important of which are radioisotope perfusion lung scans and pulmonary arteri-
`ography (see Diagnosis. below). The symptoms and signs vary in frequency and -ntensity depending
`on the extent of pulmonary vascular occlusion, the development of Pl, and the patients preembolic
`cardiopulmonary mrictiori. There may be no symptoms with small thromboemboli.
`Embolism without infarction is manifested by breathlessness. which may be the only syrnptorn if
`infarction does not develop. Tachypnea is a consistent and often striking leatr_re. Anxiety and rest-
`lessness may be prominent.
`Pulmonary hypertension, if severe. may cause dull substernal chest drscornfort due to pulmonary
`artery distention or possibly myocardial rschemla, it may be manifested by a
`increase in the intensity
`of the pulmonary component of the basal 2nd sound or abnormal splitting rise. w. ened with less
`variation of splitting during inspiration) or’ ‘me aortic and pulmonary components of the basal 2nd
`sound.
`ll‘ pulmonary vascular obstruction ‘s massive. acute RV insufficiency may supen he, with
`distended cervical veins. RV heave, RV presystolic or protodrastolic gallop, sometimes w
`arterial
`hvpotension and evidence of peripheral vasoconstriction. Lightheadedness, syncopal episodes. con-
`vJlSlV€: phenomena. and neurologic deficits may be the presenting events in a significant number of
`patients. usually reflecting a transient fall in CO with secondary cerebral ischemia. Cyanosis is usual
`in patients with massive embolism, out riot with lesser obstruction.
`
`
`
`
`
`Page 9
`
`
`Page 9
`
`

`
`§4
`504 Pulmonary Disorders
`Examination of the lungs lS usually normal in the absence 0:‘ Pl. Wheezing is sometimes heard,
`particularly it underlying bronchopulmonary or cardiac disease is present.
`In addition to the above symptoms and signs. the manifestations of Pi include cough. hemoptys-
`is, pleuritic chest pain, fever, and signs of pulmonary consolidation or pleural fluid. A pleural friction
`rub may be heard. A small. peripheral embolus may cause infarction but not obstruct the pulmonary
`arteries to the extent that pulmonary hypertension develops.
`The manifestations of embolization usuallydevelop abruptly in minutes: those of infarction over a
`period of hours. They often last several days, depending on the rate of clot lysis and other factors,
`but usually decrease daily in intensity. tn patients with chronic, recurrent emboli, the symptoms and
`signs of chronic cor puimonale tend to develop insidiously during weeks, months. or years.
`Diagnosis and Differential Diagnosis
`The diagnosis of PE with or without infarction is often difficult to establish. Differential diagnosis
`in patients with massive PE includes bacteremic shock. acute myocardial infarction (Ml), peritonitis,
`and cardiac tamponade. Without infarction. the patient's symptoms and signs may be attributed to
`anxiety with hyperventilation because of the paucity of objective pulmonary findings. When infarc-
`tion occurs. the differential diagnosis includes pneumonia, atelectasis, heart failure. and pericarditis.
`A systematic approach to diagnosis is outlined below.
`1. The clinical symptoms and signs should suggest the diagnosis.
`2. Appropriate clinical diagnostic studies, Including chest may, ECG, CBC. and serum enzyme
`{ASP LDH) and serum bilirubin determinations may be helpful. With infarction, the chest x-ray
`f'e>f;i..-ently shows a be pheral inllitrative lesion. often involving the costophrenic angle. with elc-va~
`tion of the diaphragm and pleural fluid on the affected side. Dimiriishecl pulmorsary vascular rnarkirsgs
`in the ernbolized area maybe noted in the absence of infarction. Dilation of the pulmonary arteries ir:
`the hilar area. the superior vena cava, and the azygos vein signal pulmonary hypertension and Fly
`strain Since ECG changes are characteristically transient, serial tracings are often helgirui
`in the
`diagnosis and in the exclusion of acute Ml. Changes most treciuernly seen in the ECG irecliide P
`pulmonale, rzght bundle branch block. right axis deviation. and supraventricular arrhythmies. The
`sensitivity and specificity of serum enzyme studies have been disappointing and the studies are
`rarely helpful in diagnosis. The triad of elevated serum LDH and bilirubin and normal AST (S60?)
`occurs in < ‘i 5% of patients vvith acute PE and Pl. Elevated LDH may be demonstrable in as many as
`85% of patients with Pl. but is nonspecific. occurring also in heart iailure,,snocl<, pregnancy. renal
`and live’ disease, anerrva. pneurnocra, carcinoma. and alter surgical procedures, A profile ct’ enzyme
`studies involving elevated LDH, normal CK, and normal hydroxybutyrate dehydrogenase (HBO) is
`more specific in the diagnosis of Pl and may differentiate acute Ml, but is of little value in diagnosing
`PE without Pl. Blood levels of fibrin split products appear to rise rather consistently after PE wheth-
`er Pl occurs or not. but the interval of time between this rise and the onset of symptoms, and its
`durateon, vary considerably. The specificity of this finding is also questionable since the incidence of
`elevation in other diseases is not well defined.
`’
`3. Radioisotope perfusion lung scanning, sometimes combined with ventilation scanning. is
`very valuable in estabfishing the diagnosis. Lung perfusion scans tollow lV injection of 20» to 50»
`pm particles of biodegradable albumin labeled with technetium 99th. These particles traverse the
`right heart and. via the pulmonary arteries, ultimately lodge in the small precapillary arterioles of both
`lungs. Nearly 100% of the particles remain an the lungs, except whc
`right~to—left shunting is present
`either at the cardiac or oulmoriic level. Regional distribution of these particles is direcfly proportional
`to regional pulmonary arteriolar blood flow. This distribution is relatively homogeneous in normal
`persons, but visible actii/ty is greater at the base and gradually diminishes up to the apex, reflecting
`gravitational effects on perfusion when the patient is injected in the sitting position. The distribution
`of particles depends on the posit=ori of the patient and pulmonary blood flow distribution at the time
`oi njecticn. Perfusion delicit, with reduced or absent radioactivity may result from vascular obstruc-
`tion, displacement of lung by fluid. chest masses. any condition causing pulmonary arterial or venous
`hypertensiori, or loss of lung parenchyma as in pulmonary

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket